Rachel Lippmann
Lippmann returned to her native St. Louis after spending two years covering state government in Lansing, Michigan. She earned her undergraduate degree from Northwestern University and followed (though not directly) in Maria Altman's footsteps in Springfield, also earning her graduate degree in public affairs reporting. She's also done reporting stints in Detroit, Michigan and Austin, Texas. Rachel likes to fill her free time with good books, good friends, good food, and good baseball.
-
After Republican lawmakers in Missouri refused to implement voter-approved Medicaid expansion in the state, state Supreme Court justices say low-income individuals must have access to care. -
A circuit attorney has withdrawn an invasion of privacy case against Missouri Gov. Eric Greitens — just as the case was getting started. NPR's Ari Shapiro talks to Rachel Lippmann of St. Louis Public Radio about what happens next.
-
The fallout from a scathing federal report on the police and court in Ferguson, Mo., has begun.The city's municipal judge has resigned, and a state appeals judge will start hearing cases instead.
-
Rioting broke out in the St. Louis suburb of Ferguson, where police shot and killed an unarmed teenager on Sunday. The FBI has opened an investigation into the fatal shooting that preceded the riots.
-
Among the dozens of athletes hoping to leap, throw or run their way to London as part of the U.S. track and field team is St. Louis native Shannon Leinert. The 24-year-old runner has dreamed of the Olympics since she was 10. If that weren't enough, Leinert is also working on a doctoral degree. -
David Peacock, the last executives to serve at Anheuser-Busch before and after it was takeover by Belgian brewer InBev, resigned from the company Monday. Peacock has been replaced by Luiz Edmond, but he'll remain as an adviser.
-
Express Scripts and Medco Health Services manage the prescription drug coverage that health insurance companies offer to large organizations. The two firms say their plans for a $29 billion merger will help control health care costs for consumers. But will bigger really be better?
